|
HY-100360-10mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-100mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-25mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-5mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-50mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100405-1mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100405-10mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100405-5mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100429-1mg
|
MedChemexpress LLC
|
CAN508 [CAS 140651-18-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100429-10mg
|
MedChemexpress LLC
|
CAN508 [CAS 140651-18-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100429-25mg
|
MedChemexpress LLC
|
CAN508 [CAS 140651-18-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100429-5mg
|
MedChemexpress LLC
|
CAN508 [CAS 140651-18-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100429-50mg
|
MedChemexpress LLC
|
CAN508 [CAS 140651-18-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100444-10mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100444-100mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100444-25mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100444-5mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100444-50mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100517-1mg
|
MedChemexpress LLC
|
TP-472 [CAS 2079895-62-6]
|
|
Cancer-programmed cell death
|
|
|
HY-100518-10mg
|
MedChemexpress LLC
|
T-26c [CAS 869296-13-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-100518-25mg
|
MedChemexpress LLC
|
T-26c [CAS 869296-13-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-100518-5mg
|
MedChemexpress LLC
|
T-26c [CAS 869296-13-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-100518-50mg
|
MedChemexpress LLC
|
T-26c [CAS 869296-13-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-100536-10mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-100mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
